JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
DNLI Financials - Denali Therapeutics Income & Cash Flow | Ledgeburg
DNLI - Denali Therapeutics Inc.
USD | NASDAQ | Healthcare
Summary
Summary DNLI Stock
Financials
Financials DNLI Stock
Loading...
Loading...
Income Statement
Income Statement DNLI Stock
Balance Sheet
Balance Sheet DNLI Stock
Cash Flow Statement
Cash Flow Statement DNLI Stock
Loading...
Loading...
Home
Stocks
Denali Therapeutics Inc. (DNLI)
Financials
Financials of DNLI
Loading...
Loading...
Loading...
Loading...
Revenue
$0
Operating Income
$-555.342M
Net Income
$-512.54M
Share Count (Basic)
172.649097M
Operating Cash Flow
$-412.6M
Free Cash Flow
$-422.102M
Cash And Short-Term Equivalents
$867.879M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-500M
-400M
-300M
-200M
-100M
Annual
Quarterly
Margins
Gross
Operating
Net
-600%
-400%
-200%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-132M
-130M
-128M
-126M
-124M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
No data available